High Prevalence of dam and fimA , Biofilm Formation, and Antibiotic Resistance in Uropathogenic Escherichia coli
Abstract
Background: Urinary tract infections (UTIs) are among the most common bacterial infections in women and remain a significant public health problem. Uropathogenic E. coli (UPEC) is the main cause of UTIs and can form biofilms, which lead to recurrent infections and antibiotic resistance. Type 1 fimbriae in UPEC, encoded by the fim operon, facilitate bladder attachment, while the dam an orphan DNA methyltransferase in E. coli, contributes to bacterial colonization and biofilm formation. Data on the association between antibiotic susceptibility, fimA and dam gene prevalence, and biofilm formation in UPEC isolates from UTI patients in Indonesia remain limited. This study aimed to investigate the association of the dam and fimA virulence genes with biofilm formation in UPEC causing UTIs.
Materials and Methods: Fifty UPEC isolates were obtained from a clinical microbiology laboratory. Biofilm formation was assessed using the tube method. Antibiotic susceptibility testing was performed using the Kirby–Bauer disk diffusion method with amoxicillin, ciprofloxacin, and gentamicin. The presence of the dam and fimA was determined by PCR.
Results: Seventy percent of UPEC isolates were capable of biofilm formation. High resistance rates were observed for amoxicillin (92%), ciprofloxacin (88%), and gentamicin (56%). In UPEC isolates that were positive for the dam, 62% of them had the ability to form biofilms. Meanwhile, in UPEC isolates that were positive for the fimA, 52% of them had the ability to form biofilms.
Conclusion: UPEC isolates showed a high prevalence of the dam and fimA genes, which were associated with biofilm formation and increased antibiotic resistance.
Keywords: biofilm, antibiotic, dam, fimA, urinary tract infections
Full Text:
PDFReferences
Lila ASA, Rajab AAH, Abdallah MH, Rizvi SMD, Moin A, Khafagy ES, et al. Biofilm lifestyle in recurrent urinary tract infections. Life (Basel). 2023; 13(1): 148, CrossRef.
Alshaikh SA, El-banna T, Sonbol F, Farghali MH. Correlation between antimicrobial resistance, biofilm formation, and virulence determinants in uropathogenic Escherichia coli from Egyptian hospital. Ann Clin Microbiol Antimicrob. 2024; 23(1): 20, CrossRef.
Lila ASA, Rajab AAH, Abdallah MH, Rizvi SMD, Moin A, Khafagy ES, et al. Biofilm lifestyle in recurrent urinary tract infections. Life (Basel). 2023; 13(1): 148, CrossRef.
Alshaikh SA, El-banna T, Sonbol F, Farghali MH. Correlation between antimicrobial resistance, biofilm formation, and virulence determinants in uropathogenic Escherichia coli from Egyptian hospital. Ann Clin Microbiol Antimicrob. 2024; 23(1): 20, CrossRef.
Alshaikh SA, El-Banna T, Sonbol F, Farghali MH. Correlation between antimicrobial resistance, biofilm formation, and virulence determinants in uropathogenic Escherichia coli from Egyptian hospital. Ann Clin Microbiol Antimicrob. 2024;23:20, CrossRef.
Ku JH, Tartof SY, Contreras R, Ackerson BK, Chen LH, Reyes IAC, et al. Antibiotic resistance of urinary tract infection recurrences in a large integrated US healthcare system. J Infect Dis. 2024; 230(6): e1344-54, CrossRef.
Tolenada CPS, Dayrit GB. Presence of blaCTXM-1, blaCTXM-9, and blaTEM-1 genes in extended-spectrum β-lactamase-producing Escherichia coli isolates from hospital wastewater. Indonesi Biomed J. 2023; 15(5): 278-87, CrossRef.
Trinchera M, Midiri A, Mancuso G, Lagrotteria MA, De Ani CA, Biondo C. A four-year study of antibiotic resistance, prevalence and biofilm-forming ability of uropathogens isolated from community- and hospital-acquired urinary tract infections in southern italy. Pathogens. 2025; 14(1): 59, CrossRef.
Mancuso G, Midiri A, Gerace E, Marra M, Zummo S, Biondo C. Urinary Tract Infections: The Current Scenario and Future Prospects. Pathogens. 2023; 12(4): 623. doi: 10.3390/pathogens12040623, CrossRef.
Boya BR, Lee J, Lee J. Broad Spectrum antimicrobial and antibiofilm activities of halogenated anilines against uropathogenic Escherichia coli and ESKAPE pathogens. Microb Biotechnol. 2025; 18(5): e70165, CrossRef.
Isidro-Coxca MI, Ortiz-Jiménez S, Puente JL. Type 1 fimbria and P pili: regulatory mechanisms of the prototypical members of the chaperone-usher fimbrial family. Arch Microbiol. 2024; 206(9): 373, CrossRef.
Has EG, Akçelik N, Akçelik M. Comparative global gene expression analysis of biofilm forms of Salmonella Typhimurium ATCC 14028 and its seqA mutant. Gene. 2023; 853: 147094, CrossRef.
Oğuz SK, Has EG, Akçelik N, Akçelik M. Phenotypic impacts and genetic regulation characteristics of the DNA adenine methylase gene (dam) in Salmonella typhimurium biofilm forms. Res Microbiol. 2023; 174: 103991, CrossRef.
Gao Q, Lu S, Wang Y, He L, Wang M, Jia R, et al. Bacterial DNA methyltransferase: A key to the epigenetic world with lessons learned from proteobacteria. Front Microbiol. 2023; 14: 1129437, CrossRef.
Zhao H, Dufour D, Ghobaei N, Bozec L, Lévesque CM. DNA adenine methylation influences gene expression and biofilm formation in Streptococcus mutans. Appl Environ Microbiol. 2025; 91(10): e01094-25, CrossRef.
Hamid SAA, Khoshabeh RM. Antibiotic Resistance, Biofilm Formation, and Identification of FimH and FimA Adhesion Genes in Uropathogenic Escherichia Coli (UPEC) Isolated from Patients in Baghdad Province. Iraqi J Sci. 2024; 65(10): 5546-54, CrossRef.
Liu Q, Zhu J, Liu N, Sun W, Yu B, Niu H, et al. Type I fimbriae subunit fimA enhances Escherichia coli biofilm formation but affects L-threonine carbon distribution. Front Bioeng Biotechnol. 2022; 10: 904636, CrossRef.
Mahale RP, K A, Princy A, Maheshwarappa YD, Sumana MN. Comparative evaluation of biofilm-forming capacity in uropathogenic and commensal Escherichia coli. Front Cell Infect Microbiol. 2025; 15: :1570422, CrossRef.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, 33rd Edition (CLSI M100) [cited 2026 Feb 4]. Available from: https://studylib.net/doc/27318689/clsim100ed33-2023, article.
Wijaya IGHA, Purbowati R. Identifikasi pola bakteri pada urine pengguna kateter dengan infeksi saluran kemih di RSUD dr. Soetomo Surabaya. Medika Kartika: Jurnal Kedokteran dan Kesehatan. 2022; 5: 244-54, CrossRef.
Behzadi P, Urbán E, Gajdács M, Behzadi P, Urbán E, Gajdács M. Association between Biofilm-production and antibiotic resistance in uropathogenic Escherichia coli (UPEC): an in vitro study. Diseases. 2020; 8(2): 17. doi: 10.3390/diseases8020017, CrossRef.
Haval M, Unakal C, Ghagane SC, Pandit BR, Daniel E, Siewdass P, et al. Biofilms exposed: innovative imaging and therapeutic platforms for persistent infections. Antibiotics. 2025; 14(9): 865, CrossRef.
Grari O, Ezrari S, El YI, Benaissa E, Ben LY, Lahmer M, et al. A comprehensive review on biofilm-associated infections: Mechanisms, diagnostic challenges, and innovative therapeutic strategies. The Microbe. 2025; 8: 100436, CrossRef.
Mirzahosseini HK, Najmeddin F, Najafi A, Ahmadi A, Sharifnia H, Khaledi A, et al. Correlation of biofilm formation, virulence factors, and phylogenetic groups among Escherichia coli strains causing urinary tract infection: A global systematic review and meta-analysis. J Res Med Sci. 2023; 28: 66, CrossRef.
Sultan AM, Nabiel Y. Tube method and Congo red agar versus tissue culture plate method for detection of biofilm production by uropathogens isolated from midstream urine: Which one could be better?. Afr J Clin Exp Microbiol. 2019; 20(1): 60-6, CrossRef.
Purbowati R, Utami SL. Increased expression of pap and sfa Genes in Biofilm-Forming Uropathogenic Escherichia coli Associated with Urinary Tract Infections. Molecular and Cellular Biomedical Sciences. 2025; 9: 69-75, CrossRef.
Purbowati R, Utami SL, Raharjo D, Masfufatun M. Detection of csg and lux genes in biofilm-forming uropathogenic Escherichia coli associated with urinary tract infections. J Multidiscip Appl Nat Sci. 2025; 5(1): 1-9, CrossRef.
Castillo FYR, Barrera ALG, Harel J, González FJA, Vogeleer P, Guerra JMA, et al. Biofilm Formation by Escherichia coli Isolated from Urinary Tract Infections from Aguascalientes, Mexico. Microorganisms. 2023; 11(12): 2858. doi: 10.3390/microorganisms11122858, CrossRef.
Issazadeh K, Naghibi SN, Khoshkholgh-Pahlaviani MRM. Drug resistance and serotyping of uropathogenic Escherichia coli among patients with urinary tract infection in Rasht, Iran. Zahedan J Res Med Sci. 2015; 17(6), CrossRef.
Paramita DA, Nasution K, Lubis NZ. Microbial Patterns and Antimicrobial Susceptibility on Pediatric Patients with Pressure Ulcers. Mol Cell Biomed Sci. 2019; 3(1): 17-21), CrossRef.
Sarra S, Joseph Arsene MM, Grigorievna V, Podoprigora I, Vyacheslavovna Y. Antibiotic resistance pattern of uropathogenic Escherichia coli isolated from children with symptomatic urinary tract infection in Moscow, Russia. Int J One Health. 2021; 7(2): 212-9), CrossRef.
Rozwadowski M, Gawel D. Molecular factors and mechanisms driving multidrug resistance in uropathogenic Escherichia coli-an update. Genes. 2022; 13(8): 1397, CrossRef.
Ranjbar R, Tavanania S, Sabokbar A, Khamesipour F. Prevalence and characterization of plasmid-mediated quinolone resistance genes among Escherichia coli strains isolated from different water sources in Alborz Province, Iran. Indones Biomed J. 2019; 11(1): 36-41, CrossRef.
Bakhtiari NM, Tulabi Z, Alishahi M. Biofilm-producing ability and antibiotic resistance pattern of pathogenic strains of Aeromonas hydrophila. Jundishapur J Microbiol. 2019; 12(2): e97640, CrossRef.
Ruchiatan K, Rizqandaru T, Satjamanggala PR, Tache N, Cahyadi AI, Rezano A, et al. Characteristics of biofilm-forming ability and antibiotic resistance of Cutibacterium acnes and Staphylococcus epidermidis from acne vulgaris patients. Clin Cosmet Investig Dermatol. 2023; 16: 2457-65, CrossRef.
Wang M, Xiong D, Wang X, Gu D, Meng C, Jiao X, et al. The DNA adenine methylase of Salmonella enteritidis promotes their intracellular replication by inhibiting arachidonic acid metabolism pathway in macrophages. Front Microbiol. 2023; 14: 1080851, CrossRef.
Whelan S, Lucey B, Finn K. Uropathogenic Escherichia coli (UPEC)-associated urinary tract infections: the molecular basis for challenges to effective treatment.Microorganisms. 2023; 11(9): 2169, CrossRef.
Ballén V, Cepas V, Ratia C, Gabasa Y, Soto SM. Clinical Escherichia coli: From Biofilm Formation to New Antibiofilm Strategies. Microorganisms. 2022; 10(6): 1103, CrossRef.
Mumin YM, Yüksel G, Özad Düzgün A. Investigation of virulence factor genes and biofilm formation of antibiotic resistant clinical E. coli isolates. Microb Pathog. 2025; 199: 107257, CrossRef.
DOI: https://doi.org/10.21705/mcbs.v10i1.761
Copyright (c) 2026 Molecular and Cellular Biomedical Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
![]()
